Comparison Between Anatomic Shoulder Arthroplasty, Hemiarthroplasty, and Reverse Shoulder Arthroplasty.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age70+
SponsorRobert Jones and Agnes Hunt Orthopaedic and District NHS Trust

About this trial

This study aims to evaluate outcomes in patients over 70 years of age who underwent anatomic shoulder arthroplasty, hemiarthroplasty, or reverse shoulder arthroplasty, focusing on revision rates, rotator cuff integrity as primary and Oxford Shoulder Scores as secondary outcome measures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

All patients who have had a shoulder replacement within the last 10 years anatomic, reverse, or hemi-arthroplasty and who are aged over 70 at the time of surgery will be included.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

110 Participants
are grouped into 3 trial groups
Group A: Anatomic Shoulder Arthroplasty
Group B: Hemiarthroplasty
Group C: Reverse Shoulder Arthroplasty

Trial outcomes

Primary outcomes

1

Rotator cuff failure

Information will be retrieved from the UK National Joint Registry in. Patients that had a shoulder replacement-anatomic, reverse, or hemi-arthroplasty. This will indicate the failure rate of these types of shoulder replacement.

Time frame
within the last 10 years

Secondary outcomes

1

Oxford Shoulder Score (OSS)

The study population includes patients with recorded Oxford Shoulder Scores at a minimum of one year and a maximum of seven years postoperatively. The lower the score indicates the greatest disability.

Time frame
within the last 7 years

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: